The Risk Associated to the Lack of Information About Clove Cigarettes
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
The Economics of Tobacco in Egypt a New Analysis of Demand
HNP DISCUSSION PAPER Public Disclosure Authorized Public Disclosure Authorized Economics of Tobacco Control Paper No. 8 The Economics of Tobacco in Egypt About this series... A New Analysis of Demand This series is produced by the Health, Nutrition, and Population Family (HNP) of the World Bank’s Human Development Network. The papers in this series aim to provide a vehicle for publishing preliminary and unpolished results on HNP topics to encourage discussion and Public Disclosure Authorized Public Disclosure Authorized debate. The findings, interpretations, and conclusions expressed in this paper are entirely those of the author(s) and should not be attributed in any manner to the World Bank, to its affiliated organizations or to members of its Board of Executive Directors or the countries they represent. Citation and the use of material presented in this series should take into Heba Nassar account this provisional character. For free copies of papers in this series please contact the individual authors whose name appears on the paper. Enquiries about the series and submissions should be made directly to the Editor in Chief Alexander S. Preker ([email protected]) or HNP Advisory Service ([email protected], tel 202 473-2256, fax 202 522-3234). For more information, see also www.worldbank.org/hnppublications. The Economics of Tobacco Control sub-series is produced jointly with the Tobacco Free Initiative of the World Health Organization. The findings, interpretations and conclusions expressed in this paper are entirely those of the authors and should not be attributed in any Public Disclosure Authorized Public Disclosure Authorized manner to the World Health Organization or to the World Bank, their affiliated organizations or members of their Executive Boards or the countries they represent. -
Description of the Tobacco Market, Manufacturing of Cigarettes and the Market of Related Non-Tobacco Products
COUNCIL OF Brussels, 21 December 2012 THE EUROPEAN UNION 18068/12 Interinstitutional File: ADD 3 2012/0366 (COD) SAN 337 MI 850 FISC 206 CODEC 3117 COVER NOTE from: Secretary-General of the European Commission, signed by Mr Jordi AYET PUIGARNAU, Director date of receipt: 20 December 2012 to: Mr Uwe CORSEPIUS, Secretary-General of the Council of the European Union No Cion doc.: SWD(2012) 452 final (Part 3) Subject: COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentat ion and sale of tobacco and related products (Text with EEA relevance) Delegations will find attached Commission document SWD(2012) 452 final (Part 3). ________________________ Encl.: SWD(2012) 452 final (Part 3) 18068/12 ADD 3 JS/ic 1 DG B 4B EN EUROPEAN COMMISSION Brussels, 19.12.2012 SWD(2012) 452 final Part 3 COMMISSION STAFF WORKING DOCUMENT IMPACT ASSESSMENT Accompanying the document Proposal for a DIRECTIVE OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL on the approximation of the laws, regulations and administrative provisions of the Member States concerning the manufacture, presentation and sale of tobacco and related products (Text with EEA relevance) {COM(2012) 788 final} {SWD(2012) 453 final} EN EN A.2 DESCRIPTION OF THE TOBACCO MARKET, MANUFACTURING OF CIGARETTES AND THE MARKET OF RELATED NON-TOBACCO PRODUCTS A.2.1. The tobacco market .................................................................................................. 1 A.2.1.1. Tobacco products .............................................................................................. 1 A.2.1.2. -
Youth Bidi, Kretek, Or Pipe Tobacco Use
2013 Florida Youth Tobacco Survey: Fact Sheet 10 Youth Bidi, Kretek, or Pipe Tobacco Use Introduction The Florida Youth Tobacco Survey (FYTS) was administered in the spring of 2013 to 6,440 middle school students and 6,175 high school students in 172 public schools throughout the state. The overall survey response rate for middle schools was 83%, and the overall survey response rate for high schools was 75%. The FYTS has been conduct- ed annually since 1998. The data presented in this fact sheet are weighted to represent the entire population of public middle and high school students in Florida. About Bidis, Kreteks, and Pipe Tobacco Bidis are small brown cigarettes from India consisting of tobacco wrapped in a leaf tied together with a thread. Bidis have higher levels of nicotine, carbon monoxide, and tar than traditional cigarettes. Kreteks are cigarettes containing tobacco and clove extract. In 2009, the Food and Drug Administration banned kreteks, along with flavored cigarettes, from being sold in the United States. Pipe tobacco comes either plain or flavored and is smoked through a pipe. On previous FYTS fact sheets, bidis, kreteks, and pipe tobacco have been Figure 1. Ever Tried Bidis, Kreteks, or Pipe Tobacco 8.4 8.5 reported as “specialty tobacco” products. 9 8.0 8 7.2 7.1 Ever Tried Bidis, Kreteks, or Pipe Tobacco 7 5.9 6 In 2013, 2.5% of middle school and 5.9% of high 5 4 3.2 school students had tried smoking a bidi, kretek, or Percent 2.9 3.0 3.0 2.5 2.5 pipe tobacco at least once (Figure 1). -
Other Tobacco Products (OTP) Are Products Including Smokeless and “Non-Cigarette” Materials
Other tobacco products (OTP) are products including smokeless and “non-cigarette” materials. For more information on smoking and how to quit using tobacco products, check out our page on tobacco. A tobacco user may actually absorb more nicotine from chewing tobacco or snuff than they do from a cigarette (Mayo Clinic). The health consequences of smokeless tobacco use include oral, throat and pancreatic cancer, tooth loss, gum disease and increased risk of heart disease, heart attack and stroke. (American Cancer Society, “Smokeless Tobacco” 2010) Smokeless tobacco products contain at least 28 cancer-causing agents. The risk of certain types of cancer increases with smokeless tobacco: Esophageal cancer, oral cancer (cancer of the mouth, throat, cheek, gums, lips, tongue). Other Tobacco Products (OTP) Include: Chewing/Spit Tobacco A smokeless tobacco product consumed by placing a portion of the tobacco between the cheek and gum or upper lip teeth and chewing. Must be manually crushed with the teeth to release flavor and nicotine. Spitting is required to get rid of the unwanted juices. Loose Tobacco Loose (pipe) tobacco is made of cured and dried leaves; often a mix of various types of leaves (including spiced leaves), with sweeteners and flavorings added to create an "aromatic" flavor. The tobacco used resembles cigarette tobacco, but is more moist and cut more coarsely. Pipe smoke is usually held in the mouth and then exhaled without inhaling into the lungs. Blunt Wraps Blunt wraps are hollowed out tobacco leaf to be filled by the consumer with tobacco (or other drugs) and comes in different flavors. Flavors are added to create aromas and flavors. -
Chapter 6—Clove Oil (Eugenol)
Chapter 6—Clove Oil (Eugenol) OH CH3 O Eugenol Chapter 6: Clove oil 6-2 6 Table of Contents — Clove Oil (Eugenol) 6.1 INTRODUCTION ......................................................................................................................................... 6-4 6.2 CLOVE OIL AND EUGENOL TOXICITY TO HUMANS AND LEVELS OF CONCERN ................ 6-6 6.2.1 HEALTH EFFECTS ...................................................................................................................................... 6-7 6.2.1.A Acute Effects—Sensitization ........................................................................................................... 6-7 6.2.1.B Acute Effects—Skin, Eyes and Respiratory System ........................................................................ 6-7 6.2.1.C Acute Effects—Systemic Poisoning ................................................................................................ 6-7 6.2.1.D Effects in Human Cells .................................................................................................................... 6-8 6.2.1.E Levels of Concern for Humans ........................................................................................................ 6-8 6.2.2 PESTICIDE ILLNESS REPORTS .................................................................................................................... 6-9 6.3 EUGENOL TOXICITY TO ANIMALS AND PLANTS AND LEVELS OF CONCERN .................... 6-10 6.3.1 MAMMALS ............................................................................................................................................. -
Understanding and Managing the Transition Using Essential Oils Vs
MENOPAUSE: UNDERSTANDING AND MANAGING THE TRANSITION USING ESSENTIAL OILS VS. TRADITIONAL ALLOPATHIC MEDICINE by Melissa A. Clanton A thesis submitted in partial fulfillment of the requirements for the Diploma of Aromatherapy 401 Australasian College of Health Sciences Instructors: Dorene Petersen, Erica Petersen, E. Joy Bowles, Marcangelo Puccio, Janet Bennion, Judika Illes, and Julie Gatti TABLE OF CONTENTS List of Tables and Figures............................................................................ iv Acknowledgments........................................................................................ v Introduction.................................................................................................. 1 Chapter 1 – Female Reproduction 1a – The Female Reproductive System............................................. 4 1b - The Female Hormones.............................................................. 9 1c – The Menstrual Cycle and Pregnancy....................................... 12 Chapter 2 – Physiology of Menopause 2a – What is Menopause? .............................................................. 16 2b - Physiological Changes of Menopause ..................................... 20 2c – Symptoms of Menopause ....................................................... 23 Chapter 3 – Allopathic Approaches To Menopausal Symptoms 3a –Diagnosis and Common Medical Treatments........................... 27 3b – Side Effects and Risks of Hormone Replacement Therapy ...... 32 3c – Retail Cost of Common Hormone Replacement -
Economic Analysis of the EU Market of Tobacco, Nicotine and Related Products
Executive Agency for Health and Consumers Specific Request EAHC/2011/Health/11 for under EAHC/2010/Health/01 Lot 2 Economic analysis of the EU market of tobacco, nicotine and related products Revised Final Report 20 September 2013 Economic analysis of the EU market of tobacco, nicotine and related products Disclaimer This report was produced under the Health Programme (2008-13) in the frame of a contract with the Executive Agency for Health and Consumers (EAHC) acting on behalf of the European Commission. The content of this report represents the views of Matrix Insight and is its sole responsibility; it can in no way be taken to reflect the views of the European Commission and/or EAHC or any other body of the European Union. The European Commission and/or EAHC do not guarantee the accuracy of the data included in this report, nor do they accept responsibility for any use made by third parties thereof. In keeping with our values of integrity and excellence, Matrix has taken reasonable professional care in the preparation of this report. Although Matrix has made reasonable efforts to obtain information from a broad spectrum of sources, we cannot guarantee absolute accuracy or completeness of information/data submitted, nor do we accept responsibility for recommendations that may have been omitted due to particular or exceptional conditions and circumstances. © Matrix Insight Ltd, 2009 Any enquiries about this report should be directed to [email protected] Matrix Insight Ltd. | 20 September 2013 2 Economic analysis of the EU -
"I Always Thought They Were All Pure Tobacco'': American
“I always thought they were all pure tobacco”: American smokers’ perceptions of “natural” cigarettes and tobacco industry advertising strategies Patricia A. McDaniel* Department of Social and Behavioural Sciences, School of Nursing University of California, San Francisco 3333 California Street, Suite 455 San Francisco, CA 94118 USA work: (415) 514-9342 fax: (415) 476-6552 [email protected] Ruth E. Malone Department of Social and Behavioral Sciences, School of Nursing University of California, San Francisco, USA *Corresponding author The Corresponding Author has the right to grant on behalf of all authors and does grant on behalf of all authors, an exclusive licence (or non exclusive for government employees) on a worldwide basis to the BMJ Publishing Group Ltd and its Licensees to permit this article (if accepted) to be published in Tobacco Control editions and any other BMJPGL products to exploit all subsidiary rights, as set out in our licence (http://tc.bmj.com/misc/ifora/licence.pdf). keywords: natural cigarettes, additive-free cigarettes, tobacco industry market research, cigarette descriptors Word count: 223 abstract; 6009 text 1 table, 3 figures 1 ABSTRACT Objective: To examine how the U.S. tobacco industry markets cigarettes as “natural” and American smokers’ views of the “naturalness” (or unnaturalness) of cigarettes. Methods: We reviewed internal tobacco industry documents, the Pollay 20th Century Tobacco Ad Collection, and newspaper sources, categorized themes and strategies, and summarized findings. Results: Cigarette advertisements have used the term “natural” since at least 1910, but it was not until the 1950s that “natural” referred to a core element of brand identity, used to describe specific product attributes (filter, menthol, tobacco leaf). -
Bidi, Kretek, Or Pipe Tobacco Use
2012 Florida Youth Tobacco Survey: Fact Sheet 10 Youth Bidi, Kretek, or Pipe Tobacco Use Introduction The Florida Youth Tobacco Survey (FYTS) was administered in the spring of 2012 to 38,989 middle school students and 36,439 high school students in 746 public schools throughout the state. The overall survey response rate for middle schools was 77% and the overall response rate for high schools was 73%. The FYTS has been conducted annually since 1998. The data presented in this fact sheet are weighted to represent the entire population of public middle and high school students in Florida. About Bidis, Kreteks, and Pipe Tobacco Bidis are small brown cigarettes from India consisting of tobacco wrapped in a leaf tied together with a thread. Bidis have higher levels of nicotine, carbon monoxide, and tar than traditional cigarettes. Kreteks are cigarettes containing tobacco and clove extract. In 2009, the Food and Drug Administration banned kreteks, along with flavored cigarettes, from being sold in the United States. Pipe tobacco comes either plain or flavored and is smoked through a pipe. On previous FYTS fact sheets, bidis, kreteks, and pipe tobacco have been Figure 1. Ever Tried Bidis, Kreteks, or Pipe Tobacco 8.4 8.5 reported as “specialty tobacco” products. 9 8.0 8 7.2 7.1 Ever Tried Bidis, Kreteks, or Pipe Tobacco 7 6 In 2012, 2.5% of middle school and 7.1% of high 5 4 3.2 school students had tried smoking a bidi, kretek, or Percent 2.9 3.0 3.0 2.5 pipe tobacco at least once (Figure 1). -
Ethnic Smoking Fact Sheet -- Mtf Updated Version
TOBACCO USE AND HISPANICS Despite reductions in smoking prevalence achieved since the first Surgeon General’s report on the consequences of smoking in 1964, smoking remains the leading cause of preventable death in the United States.1 Smoking accounts for more than 480,000 deaths in the United States each year, and is a major risk factor for the four leading causes of death: heart disease, cancer, chronic obstructive pulmonary disease, and stroke.2 Tobacco Use Among Hispanic Adults According the 2019 National Health Interview Survey (NHIS) of adults ages 18 and over, 8.8 percent of Hispanic adults in the United States are current smokers, compared to 15.5 percent of Whites, 14.9 percent of African, Americans, 20.9 percent of American Indian/Alaska Natives, and 7.2 percent of Asian Americans. Overall, 14.0 percent of U.S. adults are current smokers.3 Current smoking prevalence among Hispanics reflects nearly 46 percent decrease from 2005, when the rate was 16.2 percent. Hispanic smokers also tend to consume fewer cigarettes per day than non-Hispanic white smokers and are less likely to be daily smokers than smokers of all other racial/ethnic groups. 4 However, research also shows that—as with other immigrant groups—smoking behavior trends toward that of non-Hispanic whites as Hispanics acculturate to the United States, particularly for female Hispanics.5 While Hispanic smoking rates are low overall, differences exist within Hispanic subpopulations that are masked when surveys group Hispanics as a single population. For example, according to combined NHIS data from 2009-2013, 21.6 percent of Puerto Ricans, 18.2 percent of Cubans, 13 percent of Mexicans, and 9.2 percent of Central or South Americans are current smokers (the overall smoking prevalence for Hispanics during this time period was 13.5%).6 In addition, smoking rates are significantly higher for U.S.-born Hispanics than for foreign- born Hispanics in the U.S. -
Sacred Use, Not Abuse
Sacred Use, Not Abuse A Traditional Tobacco Booklet written for and by Native American Youth Funded by the Northern California Indian Development Council, Inc. Tobacco Use Prevention Education Grant from the CA Department of Education Contents Definition of Sacred 1 TUPE Pre-test 2 Traditional Use of Tobacco 3 Word Scramble 4 Secondhand smoke 5 Non Traditional Use 6 Elder Stories 7 Elder/Youth Photo 8 Recipe 9 More Secondhand smoke 10 Easy Maze (Non-smoker) 11 Hard Maze (Smoker) 12 Youth Artwork 13-14 Native Words for Tobacco 15 Money to Burn 16 Coyote the Trickster 17 Draw Own Anti-tobacco Ad 18 Youth Artwork 19-20 Health Benefits 21 Stressed 22 Things You Can Do 23 Invest Your Time 24 Before you Quit 25 The Four D’s 26 TUPE Post-test 27 TUPE Pledge 28 The Use Of Sacred Tobacco Is Our Tradition SACRED sa•cred (say-Kred) adj. 1. Dedicated to or set apart for worship. 2. Worthy of religious veneration. 3. Made or declared holy. 4. Dedicated or devoted exclusively to a single use, purpose, or person. 5. Worthy of respect; venerable. 6. Of or relating to religious objects, rites, or practices. Tribal Elders are dedicated to keeping tobacco sacred. Tobacco is offered to the creator of the earth, for our land, our fish, our acorns, our life. The creator gives us many gifts. These gifts must be respected and used in their proper way. Tobacco is a gift to be used in a sacred way with respect. Woven bag in which tobacco is carried home. -
The Effects of Eugenol, Trans-Cinnamaldehyde, Citronellol
molecules Article The Effects of Eugenol, Trans-Cinnamaldehyde, Citronellol, and Terpineol on Escherichia coli Biofilm Control as Assessed by Culture-Dependent and -Independent Methods Magdalena A. Olszewska 1,* , Astrid G˛edas 1 and Manuel Simões 2,* 1 Department of Industrial and Food Microbiology, Faculty of Food Science, University of Warmia and Mazury in Olsztyn, Plac Cieszy´nski1, 10-726 Olsztyn, Poland; [email protected] 2 LEPABE–Department of Chemical Engineering, Faculty of Engineering, University of Porto, 4200-465 Porto, Portugal * Correspondence: [email protected] (M.A.O.); [email protected] (M.S.); Tel.: +48-89-5233729 (M.A.O.); +351-22508-1654 (M.S.); Fax: +351-22508-1449 (M.S.) Received: 14 May 2020; Accepted: 5 June 2020; Published: 6 June 2020 Abstract: Bacterial biofilms contribute to problems with preserving food hygiene, jeopardizing any conventional intervention method used by the food industry. Hence, the approach of using essential oil (EO) compounds effective in biofilm control has considerable merit and deserves in-depth research. In this study, the effect of selected EO compounds (eugenol, trans-cinnamaldehyde, citronellol, and terpineol) was assessed on Escherichia coli biofilm control by plate count, resazurin assay, and Syto® 9/PI (-/propidium iodide) staining coupled with flow cytometry (FCM) and confocal laser scanning microscopy (CLSM). The selected EO compounds effectively inhibited the growth of planktonic E. coli at low concentrations of 3–5 mM, revealing a high antimicrobial activity. EO compounds markedly interfered with biofilms too, with trans-cinnamaldehyde causing the most prominent effects. Its antibiofilm activity was manifested by a high reduction of cell metabolic activity (>60%) and almost complete reduction in biofilm cell culturability.